share_log

RBC Capital Reiterates Outperform on Applied Therapeutics, Maintains $12 Price Target

Moomoo 24/7 ·  Apr 11 10:32

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Outperform and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment